This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Transformation Through Design Thinking
Vilà, Joaquim; Camps, Xavier; Sosa, Manuel E.; Liedtka, Jeanne M.Dossier DOS-37-EInnovation and Change, Service and Operations Management, StrategyDesign thinking is a vital tool for growth and innovation. This dossier shows you how to use it successfully.Starting at €15.00
-
General Electric, 1984 (Spanish Version)
Aguilar, Francis J.; Hamermesh, Richard G.; Brainard, Caroline E.Case HBS-302S36Knowledge and CommunicationDescribe los primeros cuatro años de permanencia de Jack Welch como CEO de las ofertas de General Electric Co. con las formas Welch ha tratado de actividades de estrategia y planificación del cambio de GE y sus intentos de hacer la empresa más empresarial.Starting at €8.20
-
Transforma tu empresa con el Design Thinking
Vilà, Joaquim; Camps, Xavier; Sosa, Manuel E.; Liedtka, Jeanne M.Dossier DOS-37Innovation and Change, Service and Operations Management, StrategyTransformar la empresa requiere un enfoque de dirección que permita el cambio ordenado. El design thinking puede jugar un papel imprescindible en este proceso.Starting at €15.00
-
Bystander Intervention: USA Gymnastics and Beyond (B)
Freeman, R. Edward; Mead, Jenny; Liedtka, Jeanne M.; Grushka-Cockayne, Yael; Santos, GraceCase DARDEN-E-0483-EBusiness Ethics and Corporate Social ResponsibilityThis partially disguised, public-sourced case, a follow-up to “Bystander Intervention: USA Gymnastics and Beyond (A)” (UVA-E-0482), details what happened after top gymnastics coach Megan Peterson reported team doctor Larry Nassar to USA Gymnastics leadership for his abuse of young athletes. It turned out that many others had tried to report Nassar for various instances of inappropriate behavior and abuse over the years, but coaches, trainers, adm...Starting at €5.74
-
Billie Jean King: Serving Up Leadership
Freeman, R. Edward; Grushka-Cockayne, Yael; Liedtka, Jeanne M.; Mead, JennyCase DARDEN-E-0488-EBusiness Ethics and Corporate Social ResponsibilityThroughout a lifetime of athletic success, hard work, high visibility, and professional and personal challenges both on and off the tennis court, Billie Jean King, an icon of both professional tennis, business, and activism, remained deeply committed to gender equality, social parity, and justice. In tennis and beyond, King had fought many battles, overcome many challenges, and knocked down barriers in the sports world and beyond. She had promote...Starting at €8.20
-
Bloodbuy
Hamermesh, Richard G.; Norris, MichaelCase HBS-815114-EEntrepreneurshipIn 2015, Chris Godfrey, founder and CEO of Bloodbuy has to consider the best path to growth for his young company that is attempting to disrupt the blood donation industry.Starting at €8.20
-
Amylin Pharmaceuticals B
Hamermesh, Richard G.; Knoop, Carin-IsabelCase HBS-813091-EEntrepreneurshipSupplement for case 809011Starting at €8.20
-
Novasys Medical
Hamermesh, Richard G.; Barley, LaurenCase HBS-810027-EEntrepreneurshipNovasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the product for reimbursement. The case deals with the company's struggle to obtain a reimbursement code.Starting at €8.20
-
Impact Investing for Cancer
Hamermesh, Richard G.; Preble, MatthewCase HBS-818068-EStrategyStarting at €8.20
-
Gene Patents (A)
Hamermesh, Richard G.; Kiron, David; Andrews, PhillipCase HBS-811089-EEntrepreneurshipIn March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with the potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.Starting at €8.20